HemaCare to be acquired by Charles River Laboratories for $380m
Charles River acquisition of HemaCare : Charles River Laboratories International, an early-stage contract research organization, has agreed to acquire HemaCare for about $380 million in an all-cash deal, as per the latest pharma acquisition news. HemaCare is engaged in the production of human-derived cellular products for the cell therapy market. The company provides critical biomaterials, […]